Virus Binding
Virus Binding - Related Videos
02:18
The Equilibrium Binding Constant and Binding Strength
0 Views •
2020
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium: where P and L are the unbound protein and ligand, respectively, and PL is the protein-ligand complex. As the amount of bound ligand is also related to the rate of ligand binding, experiments can also determine Kb by examining the rates of protein-ligand association (kon) and dissociation (koff) using the following ratio: Thus,...
07:02
Quantifying Human Norovirus Virus-like Particles Binding to Commensal Bacteria Using Flow Cytometry
0 Views •
Cited by 8 •
2020
The goal of this protocol is to quantify binding of the eukaryotic pathogen human norovirus to bacteria. After performing an initial virus-bacterium attachment assay, flow cytometry is used to detect virally-bound bacteria within the population.
07:51
Pull-down of Calmodulin-binding Proteins
0 Views •
Cited by 18 •
2012
Calmodulin (CaM) pull-down assay is an effective way to investigate the interaction of CaM with various proteins. This method uses CaM-sepharose beads for efficient and specific analysis of CaM-binding proteins. This provides an important tool to explore CaM signaling in cellular function.
02:40
Ligand Binding Sites
0 Views •
2020
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands. Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
01:49
Conserved Binding Sites
0 Views •
2020
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function. Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally analyses the...
FAQs
Receptor specificity determines which host cells a virus can recognize efficiently. Viral surface proteins or capsid structures interact with particular cellular receptors, attachment factors, or glycans whose molecular features complement the viral binding site. Because these molecules vary among tissues, their distribution can help explain why infection favors certain cell types and why some tissues remain less susceptible.
Attachment factors and glycans can promote the initial contact between a virus and the cell surface, increasing the opportunity for a productive receptor interaction. Their presence may therefore influence binding efficiency without alone determining whether entry follows. Studying these molecules helps distinguish surface attachment from the later receptor-dependent steps required for infection.
Complementary molecular interactions allow viral structures and cellular targets to recognize one another through matching physical and chemical features. The quality of this match influences how effectively particles remain associated with the cell and whether binding can support progression toward entry. Comparing these interactions can reveal why related viruses differ in host range, tissue preference, or susceptibility to blocking agents.
Susceptibility can change when cells differ in the presence, accessibility, or molecular form of receptors and attachment factors. A virus may bind efficiently to one cell population but poorly to another, creating a cellular barrier to infection. In immunology and infection research, these differences help connect receptor biology with disease susceptibility and patterns of tissue involvement.
A binding study examines how viral surface proteins or capsid structures interact with candidate cellular receptors, attachment factors, or glycans. Researchers can use these comparisons to identify molecular targets associated with cell recognition and to distinguish interactions that support infection from those that merely increase surface attachment. The resulting information clarifies mechanisms and potential intervention points.
Identifying the molecules involved in attachment provides targets for receptor-blocking antibodies and antiviral drugs designed to prevent or interfere with the initial interaction. The same information can guide vaccine development by highlighting viral structures that immune responses should recognize. Blocking or redirecting these contacts may reduce infection or alter which cells an engineered viral vector can reach.